Witnessing the stock’s movement on the chart, on January 05, 2022, Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) had a quiet start as it plunged -11.19% to $1.27. During the day, the stock rose to $1.445 and sunk to $1.26 before settling in for the price of $1.43 at the close. Taking a more long-term approach, SPPI posted a 52-week range of $1.23-$4.54.
Meanwhile, its Annual Earning per share during the time was -11.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -12.50%. This publicly-traded company’s shares outstanding now amounts to $159.26 million, simultaneously with a float of $137.35 million. The organization now has a market capitalization sitting at $221.30 million. At the time of writing, stock’s 50-day Moving Average stood at $1.6940, while the 200-day Moving Average is $2.6555.
Spectrum Pharmaceuticals Inc. (SPPI) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Spectrum Pharmaceuticals Inc.’s current insider ownership accounts for 0.20%, in contrast to 66.00% institutional ownership. According to the most recent insider trade that took place on Nov 09, this organization’s Chief Medical Officer sold 6,000 shares at the rate of 2.18, making the entire transaction reach 13,080 in total value, affecting insider ownership by 329,166. Preceding that transaction, on Nov 08, Company’s Chief Medical Officer sold 7,363 for 2.20, making the whole transaction’s value amount to 16,221. This particular insider is now the holder of 335,166 in total.
Spectrum Pharmaceuticals Inc. (SPPI) Earnings and Revenue Records
As on 9/29/2021, Multinational firm has announced its last quarter scores, in which it reported -$0.21 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.28) by $0.07. This company achieved a return on equity of -105.52. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
Spectrum Pharmaceuticals Inc.’s EPS decrease for this current 12-month fiscal period is -12.50% and is forecasted to reach -0.70 in the upcoming year.
Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Trading Performance Indicators
Let’s observe the current performance indicators for Spectrum Pharmaceuticals Inc. (SPPI). It’s Quick Ratio in the last reported quarter now stands at 2.40. The Stock has managed to achieve an average true range (ATR) of 0.15.
In the same vein, SPPI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.13, a figure that is expected to reach -0.16 in the next quarter, and analysts are predicting that it will be -0.70 at the market close of one year from today.
Technical Analysis of Spectrum Pharmaceuticals Inc. (SPPI)
Going through the that latest performance of [Spectrum Pharmaceuticals Inc., SPPI]. Its last 5-days volume of 10.21 million indicated improvement to the volume of 9.41 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 51.28% While, its Average True Range was 0.1500.
Raw Stochastic average of Spectrum Pharmaceuticals Inc. (SPPI) in the period of the previous 100 days is set at 3.08%, which indicates a major fall in contrast to 10.26% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 127.60% that was higher than 80.56% volatility it exhibited in the past 100-days period.